Oncology TAS: Field-Based Scientific Advocate

Bristol-Myers Squibb; Grand Rapids (MI); On-site; USD 145,000 - 175,000; Full time

Benefits offered by this job

Health Coverage

401(k) plan

Paid time off

Wellbeing programs

Employee assistance

Job summary

Bristol Myers Squibb in Grand Rapids, MI is seeking a Senior Therapeutic Area Specialist in Oncology. This field-based role engages HCPs with scientific dialogue and drives demand for BMS medicines, building credibility with regional thought leaders and clinical staff across hematology/oncology portfolios.

You will spend 100% of time in the field with external customers, collaborating cross-functionally to deliver compliant, evidence-based messaging and drive impactful patient outcomes.

Qualifications

• Advanced scientific degree and/or 5+ years of pharma/biotech sales or related healthcare role.
• Ability to communicate scientific data to physicians accurately and convincingly.
• Proven credibility with key customers and cross-functional teams.

Responsibilities

• Promotes approved indications within defined territory to meet or exceed sales targets.
• Creates demand by articulating the clinical rationale for product use in appropriate patients.
• Maintains scientific expertise across assigned products and therapeutic areas.

Skills

Advanced scientific degree

HCP communication

Credibility with customers

Hematology/Oncology

Account management

Cross-functional collaboration

Selling skills

Education

Advanced scientific degree

Tools

CE^3

CRM tools

Medical on Call

Job description

Bristol Myers Squibb in Grand Rapids, MI is seeking a Senior Therapeutic Area Specialist in Oncology. This field-based role engages HCPs with scientific dialogue and drives demand for BMS medicines, building credibility with regional thought leaders and clinical staff across hematology/oncology portfolios.

You will spend 100% of time in the field with external customers, collaborating cross-functionally to deliver compliant, evidence-based messaging and drive impactful patient outcomes.